Big Data in Biomedical: Quantum and AI to Problem Solve and Optimize

Published on : Published by : Erika Riley

The BioHealth Capital Region Forum offered many insights into the state of the industry, but the most prevalent theme was certainly big data. Panelists and keynote speakers across multiple events spoke about the importance of data in the biohealth and life sciences industry and how artificial intelligence will help the sector innovate.

5 Questions with Nur A. Hasan, Ph.D., MBA, CEO of EzBiome Inc.

Published on : Published by : Andy Eckert

Dr. Hasan is a molecular microbiologist specialized in genomics, microbiome R&D, and strategic development of technology innovation in the biotech and life science industries. His work has resulted in multiple patents and hundreds of peer-reviewed articles, abstracts, and conference proceedings in the field of microbial genomics, microbiome, molecular ecology, and infectious diseases.

5 Questions with Jacque Myers, Healthcare and Life Sciences Lead, Slalom, LLC.

Published on : Published by : Andy Eckert

Jacque Myers has 15 years of experience working across the health ecosystem, specializing in evidence-based communications to promote healthy behaviors and advance large-scale business transformations. She has focused on digital health acceleration for the last six years, including connected health, workflow automation, and research dissemination and implementation.

5 Questions with Brandan Jason, Automation Sales Executive, Mid-Atlantic, Opentrons

Published on : Published by : Andy Eckert

Brandan Jason is a current resident of Gaithersburg, MD, and has lived in Montgomery County for the past five years.  He grew up in upstate New York and attended St. John Fisher College.  Brandan loves to network and make new connections.  He is passionate about helping others and giving back to the community by volunteering with groups like The Miracle League and Roc Solid Foundation.  Outside of work, he also enjoys spending time with family, playing golf, and visiting craft breweries.

Gene Editing iPSCs with CRISPR/Cas9

Published on : Published by : Chris Frew

This rigorous three day program is ideal for basic research and translational biology scientists who are looking for a balanced theoretical vs. hands-on introduction to gene editing iPSCs using CRISPR/Cas9. [….]

5 Questions with Erin Lawless Miller, Esq., Vice President of Commercial Office & Corporate Counsel, Clinlogix

Published on : Published by : Andy Eckert

Erin Lawless Miller, Esq. is a lawyer and senior executive with more than fifteen years of experience in operations, sales, contracts, and proposal management. She has spent her career driving operational efficiencies, controlling costs, integrating business units, setting up international locations and subsidiaries, and managing legal matters across highly matrixed organizations. Recently, Erin successfully led several acquisitions.

5 Questions with Stephanie M. Davis, Ph.D., Program Officer, National Heart, Lung, and Blood Institute

Published on : Published by : Andy Eckert

“5 Questions With…” is a weekly BioBuzz series where we reach out to interesting people in the BioHealth Capital Region and beyond to share a little about themselves, their work, and maybe something completely unrelated. This week we welcome Stephanie M. Davis, Ph.D., Program Officer, National Heart, Lung, and Blood Institute. Stay tuned for more interviews with others from across the BioHealth Capital Region and beyond.

5 Questions with Ronald T. Piervincenzi, Ph.D., Chief Executive Officer, United States Pharmacopeia

Published on : Published by : Andy Eckert

“5 Questions With…” is a weekly BioBuzz series where we reach out to interesting people in the BioHealth Capital Region to share a little about themselves, their work, and maybe something completely unrelated. This week we welcome Ronald T. Piervincenzi, Ph.D., Chief Executive Officer, United States Pharmacopeia.